Study population
T2DM, liver disease
LIVER DISEASE
Inclusion criteria included age 30–80 years and duration of T2DM ≤ 5 years. Before the trial, participants could be treated with either metformin or lifestyle only. Exclusion criteria included treatment with anti-diabetic medication other than metformin, estimated glomerular filtration rate <50 ml/min, and known liver disease or transaminases > 2.5-fold above normal.